JAN 22, 2020 6:55 AM PST

Biosignatures detect TB infections months before symptoms appear

WRITTEN BY: Tara Fernandez

What if there was a test that could detect tuberculosis up to six months before symptoms appear? Researchers at the University of College London think a predictive diagnostic tool like this might soon become a reality, thanks to their work looking into gene expression patterns in the blood.

Tuberculosis, or TB, is caused by a slow-growing bacteria called Mycobacterium tuberculosis. This infectious pathogen thrives in oxygen-rich areas of the body, particularly the lungs, and is spread as coughs or sneezes propel it into the air. Immunocompromised people and those who live and work in crowded places such as healthcare facilities and prisons are especially at risk of contracting TB.

 

 

Diagnosis typically involves a tuberculin skin test to identify TB’s asymptomatic latent version. On the other hand, patients presenting with a persistent cough, fatigue, swelling of the lymph nodes or shortness of breath are likely to have the active form. This group is typically subjected to chest X-rays and sputum tests before physicians can make a positive TB diagnosis.

Globally, TB infections are among the top 10 causes of death, with the World Health Organization estimating that 10 million people contracted the disease in 2018. While it’s a condition that is preventable and treatable, a more accessible and reliable diagnostic remains to be developed.

Lead researcher Rishi Gupta hypothesized that mRNA biosignatures in patient blood samples could hold early, presymptomatic diagnostic clues, making them more valuable than traditional sputum samples. In research published in The Lancet Respiratory Medicine, Gupta and colleagues performed their analysis on genetic data collected from over 1000 blood samples, obtained from infected and healthy residents of South Africa, Ethiopia, The Gambia, and the UK. 

The team narrowed down potential mRNA candidates to a panel of 17 genes, which appeared to be consistently differentially expressed in TB-infected people over healthy controls. 

Speaking on the significance of their findings, Gupta said: "The emergence of gene expression signature tests, which can aid diagnosis and early treatment, provides real hope for the management of infectious diseases. In this study we identify multiple signatures to identify the onset of tuberculosis, which is extremely encouraging, potentially providing multiple targets for early detection.”

This is the first step towards a diagnostic blood test that could curtail the spread of TB, enable early antibiotic treatment interventions and prevent unnecessary deaths. 


Sources: Eurekalert, The Lancet Respiratory Medicine.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 11, 2020
Clinical & Molecular DX
Supervillain Alert! New Tech IDs Drug-Resistant Superbugs.
AUG 11, 2020
Supervillain Alert! New Tech IDs Drug-Resistant Superbugs.
The human body is made up of around 10 trillion cells. Fascinatingly, we have 10 times more bacterial cells on our bodie ...
SEP 03, 2020
Cell & Molecular Biology
Diagnosing Non-Celiac Gluten Sensitivity
SEP 03, 2020
Diagnosing Non-Celiac Gluten Sensitivity
Many clinicians once thought that only celiac disease caused gluten intolerance. But some people without it report gastr ...
SEP 07, 2020
Cell & Molecular Biology
With Nanopores, Small Samples Detect Diseases
SEP 07, 2020
With Nanopores, Small Samples Detect Diseases
If you've ever been through a battery of tests while doctors try to find a diagnosis for an ailment, you know that many ...
SEP 14, 2020
Health & Medicine
Direct Amplification: Rapid, Extraction-Free RT-qPCR Results
SEP 14, 2020
Direct Amplification: Rapid, Extraction-Free RT-qPCR Results
As the SARS-CoV-2 pandemic continues to rage across the United States and around the globe, the demand for COVID-19 test ...
SEP 18, 2020
Clinical & Molecular DX
Open Your Heart to the World's Smallest Diagnostic Probe
SEP 18, 2020
Open Your Heart to the World's Smallest Diagnostic Probe
Certain health conditions require doctors to be able to observe tissues and organs in order to tell what’s wrong. ...
OCT 23, 2020
Clinical & Molecular DX
Follow Your Heart: A Genetic Predictor of Cardiovascular Disease
OCT 23, 2020
Follow Your Heart: A Genetic Predictor of Cardiovascular Disease
Cardiovascular disease is the leading cause of death globally, resulting in the loss of nearly 18 million lives each yea ...
Loading Comments...